Jessica S. Yoon

Bexarotene blunts malignant T‐cell chemotaxis in Sezary syndrome: Reduction of chemokine receptor 4‐positive lymphocytes and decreased chemotaxis to thymus and activation‐regulated chemokine

Stephen K. Richardson, Sarah Newton, Tami L. Bach et al. · American Journal of Hematology · 2007 · 60 citations · Full text

Medicine, Immunology, Pharmacology +16

High Clinical Response Rate with Multimodality Immunomodulatory Therapy for Sézary Syndrome

Stephen K. Richardson, Julie Lin, Carmela C. Vittorio et al. · Clinical Lymphoma & Myeloma · 2006 · 41 citations

Life Sciences, Immunology, Pharmacology +12

Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome

Camille E. Introcaso, Bizhan Micaily, Stephen K. Richardson et al. · Journal of the American Academy of Dermatology · 2008 · 39 citations

Medicine, Dermatology, Dermatopathology +2

IL-21 Enhances Antitumor Responses without Stimulating Proliferation of Malignant T Cells of Patients with Sézary Syndrome

Jessica S. Yoon, Sarah M. Newton, Maria Wysocka et al. · Journal of Investigative Dermatology · 2007 · 18 citations · Full text

Life Sciences, Immunology, Oncology +14